Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease multiple endocrine neoplasia type 1
Comorbidity C0041327|pulmonary tb
Sentences 1
PubMedID- 23676166 However, given that there was no acquired drug resistance, the estimated 6.6% relapse rate (95%ci 4.3-10.1) across all three trials might be considered acceptable for a 4-month regimen in patients with non-cavitary pulmonary tb.

Page: 1